Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 98551-98600 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT04509648
Adjuvant Regional Nodal Radiation Therapy for One Week in Breast Cancer
NA
Recruiting
197 participants
Started: Jan 21, 2021 · Completed: Dec 30, 2030
1 condition
1 sponsor
1 location
NCT04645251
Polycystic Liver Disease Registry (UK)
N/A
Recruiting
500 participants
Started: Jan 21, 2021 · Completed: Dec 1, 2030
1 condition
2 sponsors
2 locations
NCT04788628
Auditory Stimulation Effects on Sleep and Memory in Patients With Epilepsy
NA
Active, not recruiting
24 participants
Started: Jan 21, 2021 · Completed: Mar 31, 2026
1 condition
1 sponsor
1 location
NCT04748237
Coronary Computed Tomographic Angiography in Intermediate-risk Chest Pain Patients
NA
Recruiting
1,600 participants
Started: Jan 21, 2021 · Completed: Dec 31, 2025
3 conditions
1 sponsor
1 location
NCT06510036
Assessment of Pancreatic Physiological and Pathological Characteristics Based on Spectral CT
N/A
Recruiting
1,500 participants
Started: Jan 21, 2021 · Completed: Jun 21, 2028
1 condition
1 sponsor
1 location
NCT04775537
OssiMend BA in Posterolateral Instrumented Lumbar Fusion
N/A
Recruiting
120 participants
Started: Jan 21, 2021 · Completed: Jan 30, 2027
2 conditions
1 sponsor
4 locations
NCT04699006
Efficacy and Adverse Effects of Olaparib in Ovarian Cancer.
N/A
Enrolling by invitation
245 participants
Started: Jan 21, 2021 · Completed: Jan 1, 2026
1 condition
1 sponsor
1 location
NCT04601857
Futibatinib and Pembrolizumab Combination in the Treatment of Advanced or Metastatic Urothelial Carcinoma
PHASE2
Active, not recruiting
43 participants
Started: Jan 21, 2021 · Completed: Aug 31, 2025
1 condition
2 sponsors
18 locations
NCT04732598
A Phase III Study of Bevacizumab and Paclitaxel in Combination with Atezolizumab As a Treatment for Locally Advanced Unresectable or Metastatic Hormone Receptor-positive HER2 Negative Breast Cancer
PHASE3
Active, not recruiting
280 participants
Started: Jan 21, 2021 · Completed: Sep 30, 2025
1 condition
2 sponsors
1 location
NCT04529070
Nightmare Rescripting and Rehearsal
NA
Recruiting
156 participants
Started: Jan 21, 2021 · Completed: Dec 31, 2025
2 conditions
1 sponsor
1 location
NCT04488354
Long-term Follow-up Study for Patients Treated With CLBR001 CAR-T
PHASE1
Enrolling by invitation
36 participants
Started: Jan 21, 2021 · Completed: Aug 31, 2036
12 conditions
1 sponsor
8 locations
NCT06760806
Evaluation of Toxicities in Patients Treated With Palliative Radiotherapy at Policlinico Sant Orsola of Bologna.
N/A
Recruiting
7,000 participants
Started: Jan 21, 2021 · Completed: Dec 31, 2027
1 condition
1 sponsor
1 location
NCT04513717
Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT Trial
PHASE3
Active, not recruiting
2,753 participants
Started: Jan 21, 2021 · Completed: Dec 31, 2033
3 conditions
2 sponsors
601 locations
NCT04913311
Predictive Biomarkers for Pneumonitis After Chemoradiotherapy and Immunotherapy in Patients With Non-small Cell Lung Cancer
N/A
Recruiting
150 participants
Started: Jan 21, 2021 · Completed: Feb 2, 2027
1 condition
1 sponsor
1 location
NCT05901064
Evaluation of Ultrasonic Scissors and Diathermy for Axillary Clearance in Breast Cancer Patients
NA
Recruiting
150 participants
Started: Jan 21, 2021 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT05971836
The Molecular Basis of Inherited Reproductive Disorders
N/A
Recruiting
600 participants
Started: Jan 21, 2021 · Completed: Mar 31, 2026
4 conditions
1 sponsor
1 location
NCT04558736
Haploidentical HCT for Severe Aplastic Anemia
PHASE2
Recruiting
21 participants
Started: Jan 21, 2021 · Completed: Jul 1, 2030
2 conditions
1 sponsor
1 location
NCT04341623
Xerosis and Use of Topical Moisturizer
NA
Active, not recruiting
35 participants
Started: Jan 21, 2021 · Completed: Dec 31, 2025
1 condition
2 sponsors
1 location
NCT04206644
Systemic Sclerosis and Jak Inhibitors : Emphasis on Macrophages
N/A
Active, not recruiting
150 participants
Started: Jan 21, 2021 · Completed: Feb 13, 2027
1 condition
1 sponsor
1 location
NCT04415853
Study of Larotinib in Unresectable Advanced or Recurrent Esophageal Cancer
PHASE3
Recruiting
416 participants
Started: Jan 21, 2021 · Completed: Dec 30, 2026
1 condition
1 sponsor
1 location
NCT04702009
Efficacy and Safety of First-line Anti-PD-1/PD-L1 Monoclonal Antibody in Combination With Chemotherapy and Bronchoscopy-assisted Interventional Therapy in Patients With Advanced Central Non-small Cell Lung Cancer
PHASE2/PHASE3
Not yet recruiting
80 participants
Started: Jan 20, 2021 · Completed: Jan 20, 2026
2 conditions
1 sponsor
0 locations
NCT04706910
18F-DOPA II - PET Imaging Optimization
PHASE3
Recruiting
800 participants
Started: Jan 20, 2021 · Completed: Jul 31, 2026
6 conditions
1 sponsor
1 location
NCT04416750
Positioning Imatinib for Pulmonary Arterial Hypertension
PHASE2
Active, not recruiting
17 participants
Started: Jan 20, 2021 · Completed: Jul 1, 2024
1 condition
5 sponsors
4 locations
NCT04031677
Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma
PHASE3
Recruiting
250 participants
Started: Jan 20, 2021 · Completed: Apr 21, 2028
3 conditions
6 sponsors
149 locations
NCT04206059
Closed Loop Acoustic Stimulation During Sedation With Dexmedetomidine
NA
Active, not recruiting
20 participants
Started: Jan 20, 2021 · Completed: Jul 1, 2023
2 conditions
1 sponsor
1 location
NCT04710758
Multicenter Study on Laparoscopic Total Gastrectomy for Advanced Gastric Cancer
NA
Recruiting
1,018 participants
Started: Jan 20, 2021 · Completed: Dec 31, 2028
1 condition
1 sponsor
1 location
NCT04443010
Safety and Efficacy of L19TNF Plus Temozolomide Chemoradiotherapy in Patients With Newly Diagnosed Glioblastoma
PHASE1/PHASE2
Recruiting
226 participants
Started: Jan 20, 2021 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT04240626
Multimodal Analgesia Effect on Post Surgical Patient
PHASE4
Active, not recruiting
60 participants
Started: Jan 20, 2021 · Completed: Jun 24, 2026
3 conditions
1 sponsor
1 location
NCT04722185
Evaluation of the Veriton SPECT/CT System
NA
Recruiting
300 participants
Started: Jan 20, 2021 · Completed: Jan 31, 2026
1 condition
1 sponsor
1 location
NCT06057714
Quantitation and Spatial Registration of Airways Dysfunction With Dynamic 19F MRI in Cystic Fibrosis
N/A
Recruiting
30 participants
Started: Jan 20, 2021 · Completed: Dec 31, 2025
2 conditions
3 sponsors
1 location
NCT04771520
Avapritinib for the Treatment of CKIT or PDGFRA Mutation-Positive Locally Advanced or Metastatic Malignant Solid Tumors
PHASE2
Recruiting
50 participants
Started: Jan 20, 2021 · Completed: Dec 31, 2026
29 conditions
2 sponsors
1 location
NCT05240469
Automated Sperm Selection
NA
Recruiting
330 participants
Started: Jan 20, 2021 · Completed: Sep 30, 2024
1 condition
2 sponsors
1 location
NCT04626570
Impact of a Phone-based Cognitive and Behavioral Therapy on Food Addiction in Patients With Severe or Morbid Obesity
NA
Recruiting
154 participants
Started: Jan 20, 2021 · Completed: Jan 31, 2025
2 conditions
1 sponsor
9 locations
NCT04689802
To Identify Potential New Urine Marker Panel for Cancer Screening
N/A
Recruiting
2,500 participants
Started: Jan 20, 2021 · Completed: Mar 31, 2026
1 condition
1 sponsor
1 location
NCT04544189
Study Assessing the Efficacy and Safety of Treatment With Alpelisib Plus Fulvestrant Versus Placebo Plus Fulvestrant in Chinese Men and Postmenopausal Women With Advanced Breast Cancer
PHASE2
Active, not recruiting
69 participants
Started: Jan 20, 2021 · Completed: Mar 2, 2026
1 condition
1 sponsor
24 locations
NCT04893356
Impact of O6-methylguanine-DNA Methyltransferase (MGMT) Promoter Methylation and MGMT Expression on Dacarbazine Treated Sarcoma Patients (MGMT)
N/A
Active, not recruiting
75 participants
Started: Jan 20, 2021 · Completed: Jan 20, 2025
1 condition
1 sponsor
1 location
NCT04740476
An Open-Label Extension Study of STK-001 for Patients With Dravet Syndrome
PHASE2
Active, not recruiting
60 participants
Started: Jan 20, 2021 · Completed: Mar 31, 2029
1 condition
1 sponsor
17 locations
NCT05140889
Integrating Deep Learning CT-scan Model, Biological and Clinical Variables to Predict Severity of Asthma in Children
N/A
Recruiting
25 participants
Started: Jan 20, 2021 · Completed: Jun 30, 2026
1 condition
3 sponsors
1 location
NCT05573451
Comparison of the Accuracy of US, MRI and PET/CT in the Assessment of LNs in Cervical Cancer.
N/A
Active, not recruiting
91 participants
Started: Jan 20, 2021 · Completed: Dec 31, 2024
2 conditions
2 sponsors
1 location
NCT04735198
Prophylactic Cholecystectomy in Midgut NETs Patients Who Require Primary Tumor Surgery.
NA
Recruiting
100 participants
Started: Jan 20, 2021 · Completed: Feb 28, 2026
2 conditions
1 sponsor
6 locations
NCT04700774
Behavioral Activation for Depression: A Randomized Controlled Trial
NA
Active, not recruiting
117 participants
Started: Jan 20, 2021 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT04697784
Post-Approval Study of the TREO Abdominal Stent-Graft System
NA
Active, not recruiting
338 participants
Started: Jan 20, 2021 · Completed: Jul 31, 2027
1 condition
1 sponsor
40 locations
NCT04208529
A Long-term Follow-up Study in Participants Who Received CTX001
PHASE3
Enrolling by invitation
160 participants
Started: Jan 20, 2021 · Completed: Sep 30, 2039
7 conditions
2 sponsors
19 locations
NCT04698746
PENG vs Intra-articular Injection for Hip Arthroscopy
NA
Recruiting
72 participants
Started: Jan 20, 2021 · Completed: Apr 30, 2024
2 conditions
1 sponsor
1 location
NCT04608149
Prospective, Multi-center, Single-arm, Observational Study. US FDA 522 Pediatric Post Market Surveillance Study.
N/A
Active, not recruiting
36 participants
Started: Jan 20, 2021 · Completed: Nov 30, 2025
2 conditions
1 sponsor
6 locations
NCT04669496
Phase II-III Clinical Trial of PD1 Antibody (Toripalimab), Lenvatinib and GEMOX Neoadjuvant Treatment for Resectable Intrahepatic Cholangiocarcinoma With High-risk Recurrence Factors
PHASE2/PHASE3
Active, not recruiting
178 participants
Started: Jan 20, 2021 · Completed: Dec 31, 2026
4 conditions
27 sponsors
1 location
NCT07166588
Research for the Precision Medicine in the Treatment of Inflammatory Bowel Disease
N/A
Enrolling by invitation
2,000 participants
Started: Jan 20, 2021 · Completed: Dec 31, 2028
3 conditions
1 sponsor
1 location
NCT04690946
Comparing Effect and Change Processes in Cognitive Behavioral Therapy and Emotion-Focused Therapy for Depression
NA
Active, not recruiting
112 participants
Started: Jan 20, 2021 · Completed: Mar 30, 2025
1 condition
2 sponsors
1 location
NCT04530890
Interest of Circulating Tumor DNA in Digestive and Gynecologic/Breast Cancer
NA
Recruiting
1,000 participants
Started: Jan 20, 2021 · Completed: Sep 30, 2030
5 conditions
1 sponsor
1 location
NCT04722523
A Study of Cemiplimab With Chemotherapy and Immunotherapy in People With Head and Neck Cancer
PHASE1
Recruiting
40 participants
Started: Jan 20, 2021 · Completed: Jun 20, 2026
6 conditions
2 sponsors
7 locations
Previous
1
More pages
1969
1970
1971
1972
1973
1974
1975
More pages
2369
Next